Latch builds AI agents and benchmarks for biological research, steering frontier AI systems toward breakthroughs in medicine.
More than 10,000 scientists use our agents for R&D. All frontier AI labs use our benchmarks to measure what their systems can do in biology and medicine. We are the only biotechnology company referenced in the biology sections of frontier model cards.
We ground our benchmarks in real biological and clinical work in order to advance AI systems that can design and run experiments, interpret data and clinical endpoints, and advance compounds through clinical trials better than the best human experts.
We are a team of roughly 95 people in San Francisco and remote. Our investors include Lux Capital, Coatue, Fifty Years, Haystack, Jeff Dean, Alec Nielsen, and George Church.
You will be Latch's authority on cell and gene therapy. You will own the cell and gene therapy benchmarks on our roadmap, decide what correct work looks like in these modalities, and shape how our agents reason about them, from construct design through IND-enabling studies.
This is a new function at Latch. You will define what it needs as much as you will execute it.
Author and ship the cell and gene therapy benchmarks on our roadmap across discovery, development, and translation, plus the long-horizon flagships.
Be the scientific authority at Latch for all things cell therapy and gene therapy. Before Latch makes a claim in these modalities, you are the final reviewer.
Potentially collaborate on and run drug programs in the wet lab, guiding discovery and development workflows. We are considering running agent-directed drug programs in a real lab.
Work with CROs to run experiments and gather data that inform the design of our benchmarks and agents.
Build a function beyond yourself: advisors, partners, and a hiring plan.
You have spent years working hands-on in cell or gene therapy and have carried programs through real decisions.
You have strong, defensible opinions about what correct work looks like in your field.
You want to build a function, not fill a seat.
One interview will be a detailed discussion of a cell or gene therapy program you know well: the construct, the data behind each decision, and what nearly killed it.
This is a full-time, in-person position at our waterfront office in China Basin, San Francisco. The team works from the office five days a week. The role is not hybrid or remote.
Total compensation ranges from $250,000 to $400,000, depending on experience.
We believe in long-term incentive plans and provide equity and 401(k) contributions.
Benefits include a Blue Shield Platinum health plan with 100% of premiums covered, no deductible, and no out-of-pocket costs.
Daily meals, including lunch and dinner, are provided. Travel and accommodations for scientific conferences and other professional networking trips are included.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
LatchBio is a company focused on providing tools and platforms for epigenetics and epigenomics data analysis. They aim to simplify and accelerate research in this field.